VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $286 | +5.9% | 11,678 | +0.6% | 0.04% | 0.0% |
| Q1 2023 | $270 | -9.4% | 11,605 | -1.3% | 0.04% | -81.1% |
| Q4 2022 | $298 | -99.9% | 11,755 | -2.9% | 0.20% | +59.3% |
| Q3 2022 | $233,000 | -29.0% | 12,105 | -5.9% | 0.12% | -26.8% |
| Q2 2022 | $328,000 | -53.9% | 12,870 | -24.3% | 0.17% | +97.6% |
| Q4 2021 | $712,000 | -14.4% | 17,001 | -11.0% | 0.08% | -29.2% |
| Q3 2021 | $832,000 | -12.6% | 19,111 | -5.1% | 0.12% | -14.9% |
| Q2 2021 | $952,000 | -5.9% | 20,131 | +2.0% | 0.14% | -22.5% |
| Q1 2021 | $1,012,000 | – | 19,744 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |